Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem...

Area of Science:

• Stem Cell Biology
• Endocrinology
• Regenerative Medicine

Background:

• Human induced pluripotent stem (hiPS) cells offer promise for cell therapy and drug discovery.
• Generating functional pancreatic beta-cells from hiPS cells is crucial for diabetes research and treatment.

Purpose of the Study:

• To develop a straightforward protocol for differentiating hiPS cells into insulin-producing cells.
• To optimize conditions for generating pancreatic progenitor cells and subsequently insulin-producing cells.

Main Methods:

• Utilized activin A and a GSK3β inhibitor for endodermal differentiation.
• Employed retinoic acid, a bone morphogenic protein inhibitor, and a TGF-β inhibitor for pancreatic progenitor cell induction.
• Applied forskolin, dexamethasone, and a TGF-β inhibitor to promote insulin production from progenitor cells.

Main Results:

• Achieved efficient endodermal and pancreatic progenitor cell differentiation, marked by increased PDX1 and NGN3 expression.
• Successfully differentiated insulin-producing cells from pancreatic progenitor cells, with over 10% becoming insulin-positive.
• Differentiated cells demonstrated glucose-responsive human c-peptide secretion, confirming functionality.
• The protocol proved effective across five different hiPS cell lines.

Conclusions:

• A simple and efficient protocol for generating insulin-producing cells from hiPS cells has been established.
• This method holds significant potential for advancing diabetes research, drug discovery, and cell-based therapies.